You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial

Citation Tools

Article menu
Original research
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lacombe K, Hueso T, Porcher R, et al
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
BMJ Medicine 2023;2:e000427. doi: 10.1136/bmjmed-2022-000427